Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on March 24, 2020.
June 24, 2020 at 04:44 am
Share
From March 24, 2020 to March 31, 2020, the company has repurchased 9,000 shares, representing 0.18% for KRW 390.84 million. With this, the company has completed the repurchase of 9,000 shares, representing 0.18% for KRW 390.84 million under the buyback announced on March 24, 2020.
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.